Arca Biopharma | ABIO - Pre Tax Profit


Arca Biopharma reported $-29.58M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Amgen USD 1.51B 2.41B Dec/2025
Arca Biopharma USD -29.58M 694K Dec/2025
Biogen USD 377.7M 433.7M Mar/2026
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 7.49B 4.2B Mar/2026
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.14B 919M Mar/2026
Grifols EUR 257.85M 190.87M Dec/2024
Laboratory Of America USD 8.73B 8.54B Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Otsuka Holdings JPY 130.23B 54.96B Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
United Therapeutics USD 444M 6M Dec/2025